Beijing Xiantong International Technology

Xiantong Pharma is a leading Chinese biopharmaceutical company specializing in the development, production, and commercialization of radiopharmaceuticals. The company focuses on two main areas: precision diagnosis and targeted therapy, covering therapeutic fields such as oncology, neurology, and cardiovascular diseases. Xiantong has established a comprehensive radiopharmaceutical pipeline, including diagnostic agents for Alzheimer's disease and therapeutic isotopes for neuroendocrine tumors and prostate cancer. Through strategic partnerships with global leaders like ITM and GE Healthcare, the company integrates international innovation with local manufacturing capabilities. Xiantong operates multiple R&D and production bases across China to support the growing demand for nuclear medicine and theranostics.